Long-Term Beta-Blocker Use After Heart Attack Doesn’t Improve Heart Health

Translate to Spanish or other 102 languages!

Using beta-blockers for an extended period of time did not improve cardiovascular health or reduce the risk of additional heart attacks, according to a study published in the journal Heart. Image for illustration purposes
Using beta-blockers for an extended period of time did not improve cardiovascular health or reduce the risk of additional heart attacks, according to a study published in the journal Heart. Image for illustration purposes

Medical News Today

- Advertisement -
  • Beta-blockers are used to treat heart problems and high blood pressure and are commonly prescribed to people following a heart attack.
  • In a new study, researchers say long-term use of the medications following a heart attack doesn’t appear to improve cardiovascular health.
  • Experts say the observational study provides valuable information, but they note that beta-blockers are still beneficial for many people.

Using beta-blockers for an extended period of time did not improve cardiovascular health or reduce the risk of additional heart attacks, according to a study published in the journal Heart.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/study-questions-long-term-beta-blocker-use-to-curb-further-heart-attack-risk?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-04&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Small Steps in Weight Loss Lead to Big Heart Health Benefits

When people think about weight loss, they often picture dramatic transformations: a major drop on the scale, a new clothing size or a before-and-after photo. But when it comes to overall health, some of the biggest benefits can begin long before those milestone moments.

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer  

The U.S. Food and Drug Administration expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given with Bacillus Calmette-Guérin (BCG), to include adults with high-grade papillary-only bladder cancer that has not spread into the bladder muscle and has not responded to BCG treatment.

The Power of Proper Handwashing

One simple habit can go a long way toward helping you stay healthy.

Speak Up, Reach Out: STHS Behavioral Tackles Suicide Prevention

Not all wounds are visible. Every day, people struggle with emotional pain, depression and feelings of hopelessness that may go unnoticed by those around them.
- Advertisement -